FDA Inspection
Quality Chemical LaboratoriesQuality Chemical Laboratories – FDA Inspection, Jul 27, 2017
Record Details
This FDA Inspection record concerns Quality Chemical Laboratories, with an inspection on July 27, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Kara D. Dobbin (Issuing Officer)
- Tajah L. Blackburn (FDA Associated Person)
View Company Profile
ID · 05d68d67-387f-438f-9622-8917dd74cef0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1020031
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Quality Chemical Laboratories
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2025 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 20, 2024 | VAI | Atlanta District Office | Drug Quality Assurance |
| June 21, 2016 | NAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
| September 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Quality Chemical Laboratories
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.